Medication induced constipation and diarrhea

Practical Gastroenterology

Volumn 32, Issue 5, 2008, Pages 12-28

  Toney, Rachel C ^a   Wallace, Dustin ^a   Sekhon, Sandeep ^a   Agrawal, Rad M ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA GLUCOSIDASE INHIBITOR; ANTACID AGENT; ANTIDIARRHEAL AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIPARKINSON AGENT; ATROPINE PLUS DIPHENOXYLATE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CISAPRIDE; CLONIDINE; DIURETIC AGENT; ERYTHROMYCIN; ESTERASE INHIBITOR; IRON; LACTULOSE; LAXATIVE; LOPERAMIDE; NALMEFENE; NALOXONE; NALTREXONE; NEOSTIGMINE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ANAMNESIS; ANORECTAL PRESSURE; CLINICAL FEATURE; CLINICAL TRIAL; CONSTIPATION; DEFECOGRAPHY; DIAGNOSTIC PROCEDURE; DIARRHEA; DIETARY FIBER; DRUG HALF LIFE; DRUG USE; ECONOMIC ASPECT; HEALTH CARE; HUMAN; MORBIDITY; PRESCRIPTION; PREVALENCE; REHYDRATION; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 45349091920     PISSN: 02774208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Sonnenberg A, Koch TR. Physician visits in the United States for constipation: 1958 to 1986. Dig Dis Sci, 1989;34(4):606-611.
2. Locke GR, 3rd, Pemberton JH, Phillips SF, Locke GR, 3rd, Pemberton JH, Phillips SF. AGA technical review on constipation. American Gastroenterological Association. Gastroenterology, 2000;119(6):1766-1778.
3. Chassany O, Michaux A, Bergmann JF. Drug-induced diarrhoea. Drug Safety, 2000; 22(1):53-72.
4. Stewart WF, Liberman JN, Sandler RS, et al. Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features. Am J Gastroenterol, 1999;94(12):3530-3540.
5. Sonnenberg A, Koch TR. Epidemiology of constipation in the United States. Dis Col Rec, 1989;32(1):1-8.
6. Talley NJ, Fleming KC, Evans JM, et al. Constipation in an elderly community: a study of prevalence and potential risk factors.[see comment]. Am J Gastroenterol, 1996;91(1): 19-25.
7. Wald A. Constipation in elderly patients. Pathogenesis and management. Drugs & Aging, 1993;3(3):220-231.
8. Talley NJ, Weaver AL, Zinsmeister AR, et al. Functional constipation and outlet delay: a population-based study. Gastroenterology, 1993;105(3):781-790.
9. Leung FW. Etiologic factors of chronic constipation: review of the scientific evidence. Dig Dis Sci, 2007;52(2):313-316.
10. Staats PS, Markowitz J, Schein J. Incidence of constipation associated with long-acting opioid therapy: a comparative study. South Med J, 2004;97(2):129-134.
11. Lembo A, Camilleri M. Chronic constipation.[see comment]. NEJM, 2003;349(14):1360-1368.
12. Chin APMJ, van Poppel MN, van Mechelen W. Effects of resistance and functional-skills training on habitual activity and constipation among older adults living in long-term care facilities: a randomized controlled trial. BMC Geriatrics, 2006;6:9.
13. Pare P, Bridges R, Champion MC, et al. Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment. Can J Gastroenterol, 2007;21 Suppl B:3B-22B.
14. Tramonte SM, Brand MB, Mulrow CD, Amato MG, O'Keefe ME, Ramirez G. The treatment of chronic constipation in adults. A systematic review.[see comment]. J Gen Int Med, 1997;12(1):15-24.
15. Attar A, Lemann M, Ferguson A, et al. Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut, 1999;44(2): 226-230.
16. Knowles CH, Scott M, Lunniss PJ. Outcome of colectomy for slow transit constipation. Ann Sur, 1999;230(5):627-638.
17. Choi YS, Billings JA. Opioid antagonists: a review of their role in palliative care, focusing on use in opioid-related constipation. J Pain Sym Manage, 2002; 24(1):71-90.
18. Thomas MC, Erstad BL. Safety of enteral naloxone and i.v. neostigmine when used to relieve constipation. Am J Health-System Pharm, 2003;60(12): 1264-1267.
19. Freedman MD, Schwartz HJ, Roby R, Fleisher S. Tolerance and efficacy of polyethylene glycol 3350/electrolyte solution versus lactulose in relieving opiate induced constipation: a double-blinded placebo-controlled trial. J Clin Pharmacol, 1997;37(10): 904-907.
20. Herndon CM, Jackson KC, 2nd, Hallin PA. Management of opioid-induced gastrointestinal effects in patients receiving palliative care. Pharmacotherapy, 2002;22(2):240-250.
21. Kelly C. Antibiotic-Associated Diarrhea, Pseudomembranous Enterocolitis, and Clostridium difficile-Associated Diarrhea and Colitis. In: Feldman M, ed. Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 8th ed. Vol. 2. Philadelphia: Saunders Elsevier; 2006:2393-2413.
22. Riddell RH, Tanaka M, Mazzoleni G. Non-steroidal anti-inflammatory drugs as a possible cause of collagenous colitis: a case-control study. Gut, 1992;33(5):683-686.
23. Bartlett JG. Clinical practice. Antibiotic-associated diarrhea.[see comment]. NEJM, 2002;346(5):334-339.
24. Bartlett JG. Antibiotic-associated diarrhea. Clin Inf Dis, 1992;15(4):573-581.
25. Hurley BW, Nguyen CC. The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea. Arch Int Med, 2002;162(19):2177-2184.
26. Mylonakis E, Ryan ET, Calderwood SB. Clostridium difficile - Associated diarrhea: A review. Arch Int Med, 2001;161(4):525-533.
27. Katz JA. Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile diarrhea. J Clin Gastroenterol, 2006;40(3):249-255.
28. Sherman DS, Fish DN. Management of protease inhibitor-associated diarrhea. Clin Inf Dis, 2000;30(6):908-914.
29. Solomon R, Cherny NI. Constipation and diarrhea in patients with cancer. Cancer J, 2006;12(5):355-364.
30. Gibson RJ, Keefe DMK. Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies. Sup Care Can, 2006;14(9):890-900.
31. Schiller L. Diarrhea. In: Feldman M, ed. Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 8th ed. Vol. 1. Philadelphia: Saunders Elsevier; 2006:159-186.
32. Vanderhoff BT, Tahboub RM. Proton pump inhibitors: an update.[see comment]. Am Fam Phy, 2002;66(2):273-280.
33. Koksal AS, Uskudar O, Koklu S, et al. Propranolol-exacerbated mesenteric ischemia in a patient with hyperthyroidism. Ann Pharmacother, 2005;39(3):559-562.
34. Verne GN, Davis RH, Robinson ME, et al. Treatment of chronic constipation with colchicine: randomized, double-blind, placebo-controlled, crossover trial. Am J Gastroenterol, 2003;98(5):1112-1116.
35. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11th Edition, New York McGraw-Hill; 2006. (Brunton LL, ed.)